A federal judge in San Francisco has rejected a motion asking him to overturn a jury verdict and order a new trial in an epic intellectual property case. in a huge patent dispute and start a retrial from scratch. U.S. District Judge Charles Legge refused Genentech Inc.'s request to overturn jurors' recent verdict finding that the University of California's 1982 patent for human growth hormone was "enabled" or, in other words, adequate for use by other scientists.
July 09, 1999 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A San Francisco federal judge has rejected a motion asking him to throw out a favorable verdict for the University of California in a huge patent dispute and start a retrial from scratch.
U.S. District Judge Charles Legge refused Genentech Inc.’s request to overturn jurors’ June verdict that UC’s 1982 patent for human growth hormone was “enabled” or, in other words, adequate for use by other scientists.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
